The Biogen-alum startup aims to do what tolvaptan cannot, halting or reversing cyst growth in autosomal dominant polycystic kidney disease…
Confido Health has raised an additional $12.5 million in a Series A extension led by Z47, lifting the round to…
The patient-engagement startup says its AI platform grew annual recurring revenue tenfold and now serves more than 2,800 providers, mostly…
The Paris company's agents turn scientific and regulatory paperwork into auditable workflows for drug developers.
The Toronto company raised a Series A co-led by OrbiMed and Qiming Venture Partners USA for AI that reads trial…
The company says its platform can cut the time from a research idea to an investigational new drug filing by…
The startup's platform cuts adverse-event case processing from hours to minutes for pharma sponsors.
Flare Capital backs GenHealth.ai's $16.5M Series A for AI agents that finish insurance and billing work.